Target intelligence / Profile preview

BPNT2 pseudogene 1 (BPNT2P1)

Target
BPNT2P1
Molecular classification
Other (pseudogene)
01

Overview

BPNT2 pseudogene 1 is a genomic DNA sequence that is highly similar to the functional BPNT2 gene but does not produce a functional protein product. The functional BPNT2 gene encodes an enzyme that catalyzes the hydrolysis of phosphoadenosine phosphate to adenosine monophosphate and is involved in glycosaminoglycan sulfation, particularly in cartilage and bone development. However, the BPNT2 pseudogene 1 (BPNT2P1) is classified as a pseudogene and does not participate in these biochemical or physiological roles[1][2][4][5]. Key rationale: - BPNT2 pseudogene 1 is specifically annotated as a *pseudogene* and not a protein-coding gene[1][4][5]. - As a pseudogene, it does not possess catalytic activity nor recognized biological or disease functions. - There is no evidence in public databases or scientific literature indicating that BPNT2P1 produces a functional protein or acts as a therapeutic target. - The *functional* BPNT2 gene (not its pseudogene) is the entity associated with biological activity, disease relevance, and possible drug interactions[1][2][4]. - If your interest is in the functional protein, search for BPNT2, not BPNT2P1. Conclusion: BPNT2 pseudogene 1 (BPNT2P1) is not a valid molecular drug target. It does **not** encode a functional receptor, enzyme, or transporter, and there is nothing indicating therapeutic, biological, or biomarker relevance for BPNT2P1 itself. The correct therapeutic target is *BPNT2* (3'(2'),5'-bisphosphate nucleotidase 2), but not its pseudogene.

Other names
BPNT2P3'(2'), 5'-bisphosphate nucleotidase 2, pseudogeneinositol monophosphatase domain containing 1 pseudogeneBPNT2P1

Beyond the preview

Go deeper on BPNT2 pseudogene 1 (BPNT2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BPNT2 pseudogene 1 (BPNT2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call